214 related articles for article (PubMed ID: 8405743)
1. Impact of injection sites for soluble insulin on glycaemic control in type 1 (insulin-dependent) diabetic patients treated with a multiple insulin injection regimen.
Henriksen JE; Djurhuus MS; Vaag A; Thye-Rønn P; Knudsen D; Hother-Nielsen O; Beck-Nielsen H
Diabetologia; 1993 Aug; 36(8):752-8. PubMed ID: 8405743
[TBL] [Abstract][Full Text] [Related]
2. [Injection site for quick-acting insulin. Significance for glycemic control in basal bolus insulin regimen].
Henriksen JE; Djurhuus MS; Vaag AA; Thye-Rønn P; Knudsen DU; Nielsen OH; Beck-Nielsen H
Ugeskr Laeger; 1994 Aug; 156(35):4976-9. PubMed ID: 7992431
[TBL] [Abstract][Full Text] [Related]
3. Intramuscular versus subcutaneous injection of unmodified insulin: consequences for blood glucose control in patients with type 1 diabetes mellitus.
Vaag A; Pedersen KD; Lauritzen M; Hildebrandt P; Beck-Nielsen H
Diabet Med; 1990 May; 7(4):335-42. PubMed ID: 2140087
[TBL] [Abstract][Full Text] [Related]
4. A comparison of intensive mixture therapy with basal insulin therapy in insulin-naïve patients with type 2 diabetes receiving oral antidiabetes agents.
Jacober SJ; Scism-Bacon JL; Zagar AJ
Diabetes Obes Metab; 2006 Jul; 8(4):448-55. PubMed ID: 16776752
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Monotard and Ultratard insulin at bedtime in a model of optimized insulin therapy in Italy.
Martina V; Tagliabue M; Maccario M; D'Antona G; Camanni F
Diabete Metab; 1989; 15(6):372-4. PubMed ID: 2697606
[TBL] [Abstract][Full Text] [Related]
6. [The metabolic and psychological assessment of 40 adolescents with type-1 diabetes during 6 months of intensified insulin therapy using the pen injector or the traditional syringe].
Cherubini V; Guazzarotti L; Bartolotta E
Pediatr Med Chir; 1991; 13(1):67-71. PubMed ID: 2052459
[TBL] [Abstract][Full Text] [Related]
7. Clinical usefulness of serum fructosamine and HbA1 as markers for metabolic control in patients with changing insulin regimens.
Steen G; Weber RF
Diabetes Res; 1990 Apr; 13(4):177-82. PubMed ID: 2134209
[TBL] [Abstract][Full Text] [Related]
8. Long-term comparison of human insulin analogue B10Asp and soluble human insulin in IDDM patients on a basal/bolus insulin regimen.
Nielsen FS; Jørgensen LN; Ipsen M; Voldsgaard AI; Parving HH
Diabetologia; 1995 May; 38(5):592-8. PubMed ID: 7489843
[TBL] [Abstract][Full Text] [Related]
9. Preprandial vs. postprandial insulin lispro-a comparative crossover trial in patients with Type 1 diabetes.
Schernthaner G; Wein W; Shnawa N; Bates PC; Birkett MA
Diabet Med; 2004 Mar; 21(3):279-84. PubMed ID: 15008840
[TBL] [Abstract][Full Text] [Related]
10. The use of low glycaemic index foods improves metabolic control of diabetic patients over five weeks.
Fontvieille AM; Rizkalla SW; Penfornis A; Acosta M; Bornet FR; Slama G
Diabet Med; 1992 Jun; 9(5):444-50. PubMed ID: 1611832
[TBL] [Abstract][Full Text] [Related]
11. Optimal timing of injection of once-daily insulin glargine in people with Type 1 diabetes using insulin lispro at meal-times.
Ashwell SG; Gebbie J; Home PD
Diabet Med; 2006 Jan; 23(1):46-52. PubMed ID: 16409565
[TBL] [Abstract][Full Text] [Related]
12. Glycaemic control in type 1 diabetic patients using optimised insulin aspart or human insulin in a randomised multinational study.
Tamás G; Marre M; Astorga R; Dedov I; Jacobsen J; Lindholm A;
Diabetes Res Clin Pract; 2001 Nov; 54(2):105-14. PubMed ID: 11640994
[TBL] [Abstract][Full Text] [Related]
13. Effects of the anatomical region used for insulin injections on glycemia in type I diabetes subjects.
Bantle JP; Neal L; Frankamp LM
Diabetes Care; 1993 Dec; 16(12):1592-7. PubMed ID: 8299455
[TBL] [Abstract][Full Text] [Related]
14. Administration of neutral protamine Hagedorn insulin at bedtime versus with dinner in type 1 diabetes mellitus to avoid nocturnal hypoglycemia and improve control. A randomized, controlled trial.
Fanelli CG; Pampanelli S; Porcellati F; Rossetti P; Brunetti P; Bolli GB
Ann Intern Med; 2002 Apr; 136(7):504-14. PubMed ID: 11926785
[TBL] [Abstract][Full Text] [Related]
15. Absorption of NPH (isophane) insulin in resting diabetic patients: evidence for subcutaneous injection in the thigh as the preferred site.
Henriksen JE; Vaag A; Hansen IR; Lauritzen M; Djurhuus MS; Beck-Nielsen H
Diabet Med; 1991 Jun; 8(5):453-7. PubMed ID: 1830531
[TBL] [Abstract][Full Text] [Related]
16. Assessment of distance from skin surface to muscle for evaluation of the risk of inadvertent intramuscular insulin injection at potential injection sites among patients attending a tertiary care children's hospital in Sri Lanka-an observational study.
Kodikara SKYI; Kalubowila J; Atapattu N; Warapitiya DS; Wijayabandara MDMS; Jayasekara LMDT; Arunthavanathan A; Kempitiya BCTANWMRCS; de Silva KSH; de Abrew K
Arch Pediatr; 2020 Jul; 27(5):244-249. PubMed ID: 32461034
[TBL] [Abstract][Full Text] [Related]
17. Use of inhaled insulin in a basal/bolus insulin regimen in type 1 diabetic subjects: a 6-month, randomized, comparative trial.
Skyler JS; Weinstock RS; Raskin P; Yale JF; Barrett E; Gerich JE; Gerstein HC;
Diabetes Care; 2005 Jul; 28(7):1630-5. PubMed ID: 15983312
[TBL] [Abstract][Full Text] [Related]
18. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.
Pampanelli S; Torlone E; Ialli C; Del Sindaco P; Ciofetta M; Lepore M; Bartocci L; Brunetti P; Bolli GB
Diabetes Care; 1995 Nov; 18(11):1452-9. PubMed ID: 8722069
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.
Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M
Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467
[TBL] [Abstract][Full Text] [Related]
20. Effects of different glycaemic index foods and dietary fibre intake on glycaemic control in type 1 diabetic patients on intensive insulin therapy.
Lafrance L; Rabasa-Lhoret R; Poisson D; Ducros F; Chiasson JL
Diabet Med; 1998 Nov; 15(11):972-8. PubMed ID: 9827853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
